Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian Maclachlan

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Cancer Research|June 25, 2014
Antitumor effects in hepatocarcinoma of isoform-selective inhibition of HDAC2Yun-Han Lee, Daekwan Seo, Kyung-Ju Choi, et al.
Nature Biotechnology|July 26, 2005
Potent and persistent in vivo anti-HBV activity of chemically modified siRNAsDavid V Morrissey, Jennifer A Lockridge, Lucinda Shaw, et al.
Cancer Research|October 21, 2010
Definition of ubiquitination modulator COP1 as a novel therapeutic target in human hepatocellular carcinomaYun-Han Lee, Jesper B Andersen, Ho-Taek Song, et al.
Nature|March 28, 2006
RNAi-mediated gene silencing in non-human primatesTracy S Zimmermann, Amy C H Lee, Akin Akinc, et al.
Nature Biotechnology|January 19, 2010
Rational design of cationic lipids for siRNA deliverySean C Semple, Akin Akinc, Jianxin Chen, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Cancer Research|June 25, 2014
Antitumor effects in hepatocarcinoma of isoform-selective inhibition of HDAC2Yun-Han Lee, Daekwan Seo, Kyung-Ju Choi, et al.
Nature Biotechnology|July 26, 2005
Potent and persistent in vivo anti-HBV activity of chemically modified siRNAsDavid V Morrissey, Jennifer A Lockridge, Lucinda Shaw, et al.
Cancer Research|October 21, 2010
Definition of ubiquitination modulator COP1 as a novel therapeutic target in human hepatocellular carcinomaYun-Han Lee, Jesper B Andersen, Ho-Taek Song, et al.
Nature|March 28, 2006
RNAi-mediated gene silencing in non-human primatesTracy S Zimmermann, Amy C H Lee, Akin Akinc, et al.
Nature Biotechnology|January 19, 2010
Rational design of cationic lipids for siRNA deliverySean C Semple, Akin Akinc, Jianxin Chen, et al.
Pageof 4